Associations of genetically determined iron status across the phenome: A mendelian randomization study
Open accessThe DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index; 38 of the 56 sources its claims cite were checked for support.
Abstract
BACKGROUND: Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. METHODS AND FINDINGS: Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 × 10-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 × 10-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 × 10-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. CONCLUSIONS: Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation.
Overview
CoChat Summary
TL;DR
In a two-sample mendelian randomization phenome-wide association study, genetically determined higher systemic iron status was associated with lower risk of anemia and hypercholesterolemia but higher risk of skin and soft tissue infections. The authors highlight these as novel, to their knowledge, clinically relevant findings warranting further investigation.
Key findings
- Using 3 iron-status instruments (rs1800562 and rs1799945 in *HFE*, rs855791 in *TMPRSS6*) across 904 phecodes in 424,439 UK Biobank European participants, higher iron status was associated with lower risk of iron deficiency anemia (OR 0.72, 95% CI 0.64–0.81, P = 4 × 10−8) and acute posthemorrhagic anemia (OR 0.35, 95% CI 0.19–0.65, P = 1 × 10−3).
- Higher iron status was associated with lower risk of hypercholesterolemia (OR 0.88, 95% CI 0.83–0.93, P = 2 × 10−5) and cholesterolosis of the gallbladder (OR 0.45, 95% CI 0.28–0.72, P = 9 × 10−4).
- Higher iron status was associated with increased risk of skin and soft tissue infections, including cellulitis and abscess of the leg (OR 1.25, 95% CI 1.10–1.42, P = 6 × 10−4), and with glossitis (OR 2.64, 95% CI 1.56–4.46, P = 3 × 10−4).
- Higher iron status was also associated with lower risk of poisoning by antibiotics (OR 0.74, 95% CI 0.62–0.87, P = 4 × 10−4).
Methods
- Two-sample summary-data mendelian randomization (MR)–PheWAS: instruments were selected from a Genetics of Iron Status Consortium GWAS of 48,972 European individuals (55% female), using 3 SNPs concordantly associated with higher serum iron, ferritin, and transferrin saturation and lower transferrin.
- PheWAS was performed in 424,439 European UK Biobank participants aged 40–69 years recruited in 2006–2010, with genetic data linked to Hospital Episode Statistics from April 1995 to March 2016; 904 distinct phecodes with ≥200 cases were analyzed.
- Logistic regression per SNP adjusted for age, sex, genotyping array, and first 4 principal components; MR estimates used the ratio method scaled to a 1 SD increase in genetically determined serum iron (SD 6.1 μmol/L), pooled by inverse-variance weighted meta-analysis, with 5% false discovery rate correction, Cochran Q heterogeneity testing, weighted median MR sensitivity analysis, and sex-stratified estimates.
Limitations
- The paper states possible bias from pleiotropic effects of the genetic variants, misclassification of diagnoses in HES data, and restriction to European ancestry, so findings may not apply to other ethnic groups.
- The paper also states that UK Biobank lacked serum cholesterol measures, so the magnitude of effect on actual cholesterol levels and lipid fractions could not be quantified; ascertainment bias may affect the antibiotic poisoning finding, and inadequate statistical power may have produced false negatives.
- Evident from the text: only 3 SNPs were used, collectively explaining approximately 3.8% of variation in serum iron; MR estimates relate to small variations within the normal range rather than extremes of iron deficiency or overload, and exclusion of heterogeneous results may have introduced type II error.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
20 Valid · 2 Not valid · 7 Not checked · 41 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“All three of these SNPs have previously been shown to be strong instruments for MR analysis as measured by F-statistics > 10 [8,18]”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Supportedcites [8] Gill D, Del Greco M F, Walker AP, Srai SKS, Laffan MA, Minelli C. The effect of iron status on risk of coronary artery disease: a mendelian randomization study. Arterioscler Thromb Vasc Biol. 2017; 37(9): 1788– 92. 10.1161/ATVBAHA.117.309757. 28684612 source
The Results state that the three instruments have F statistics ranging from 47 to 2127 across the four iron-status markers. Table 1 lists values above 10 for each SNP, supporting the claim that all three are strong instruments by that threshold. (LLM, conf=0.94)
- Disputedcites [18] Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012; 21(3): 223– 42. 10.1177/0962280210394459 21216802 PMC3917707 sourceExperimental — accuracy not yet measured
Table 3 (§2.4) reports individual first-stage F-statistics above 10 for only two of the four SNPs studied: FTO (39.83) and MC4R (17.85). The text in §2.4 explicitly calls TMEM18 and GNPDA2 weak instruments because their F-statistics are below 10. The source therefore does not show three individual SNPs to be strong by this criterion. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“collectively explain approximately 3.8% of the variation in serum iron [2,8].”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Partly supportedcites [2] Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, et al Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun. 2014; 5: 4926 Epub 2014/10/29. 10.1038/ncomms5926 25352340 PMC4215164 sourceExperimental — accuracy not yet measured
The Results section ('SNP and gene associations'; page not available) reports that lead SNPs at eleven significant loci explained 3.4% of serum-iron variance in the replication cohorts. It supports the general point that SNPs explain some variation in serum iron, but not the attributed figure of approximately 3.8% for three SNPs. (LLM, conf=0.87)
- Supportedcites [8] Gill D, Del Greco M F, Walker AP, Srai SKS, Laffan MA, Minelli C. The effect of iron status on risk of coronary artery disease: a mendelian randomization study. Arterioscler Thromb Vasc Biol. 2017; 37(9): 1788– 92. 10.1161/ATVBAHA.117.309757. 28684612 source
Table 1 (reproduced in the Discussion; page not provided) lists serum-iron R² values of 1.3%, 0.9%, and 1.6% for the three SNPs. The table defines R² as the percentage of variation explained by each SNP; the values sum to 3.8%. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The two SNPs in the HFE gene were in low linkage disequilibrium (LD r2 < 0.01) when considering combined European populations with the LDlink resource [2,17].”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Could not verifycites [2] Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, et al Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun. 2014; 5: 4926 Epub 2014/10/29. 10.1038/ncomms5926 25352340 PMC4215164 sourceExperimental — accuracy not yet measured
The Methods section on HFE C282Y homozygotes identifies rs1800562, but does not report linkage disequilibrium between two HFE SNPs. Searches for the SNP pair, LDlink, and the claimed r² threshold found no measurement for combined European populations in our copy. (LLM, conf=0.74)
- Supportedcites [17] Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015; 31(21): 3555– 7. 10.1093/bioinformatics/btv402 26139635 PMC4626747 source
The citation identifies the LDlink resource used for the calculation, rather than citing its paper as a report of the two HFE SNPs’ result. The Implementation section describes LDpair as reporting linkage-disequilibrium measures for a pair of SNPs and says LDlink permits combinations of populations, including European populations. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A genome-wide association study (GWAS) performed by the Genetics of Iron Status Consortium on 48,972 European subjects (combined Discovery [N = 23,986] and Replication [N = 24,986] cohorts, 55% female) identified 3 such single-nucleotide polymorphisms (SNPs): rs1800562 and rs1799945 in the hemochromatosis (HFE) gene and rs855791 in the transmembrane protease serine 6 (TMPRSS6) gene [2,8,10].”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Supportedcites [2] Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, et al Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun. 2014; 5: 4926 Epub 2014/10/29. 10.1038/ncomms5926 25352340 PMC4215164 source
Methods > Subjects reports 23,986 European-ancestry discovery subjects and up to 24,986 replication subjects, totaling up to 48,972. Results > Effects at Significant Loci on Gene Expression and Regulation names rs1800562, rs1799945, and rs855791 as SNPs in HFE and TMPRSS6 from the study’s significant loci. The paper reports eleven significant loci overall; the claim identifies three SNPs, not the study’s entire set of findings. (LLM, conf=0.91)
- Partly supportedcites [8] Gill D, Del Greco M F, Walker AP, Srai SKS, Laffan MA, Minelli C. The effect of iron status on risk of coronary artery disease: a mendelian randomization study. Arterioscler Thromb Vasc Biol. 2017; 37(9): 1788– 92. 10.1161/ATVBAHA.117.309757. 28684612 sourceExperimental — accuracy not yet measured
The Abstract reports a GWAS meta-analysis of 48,972 individuals and names all three SNPs with their HFE and TMPRSS6 genes; Table 1 also lists the three SNPs. Our copy does not substantiate the sentence’s European ancestry, discovery/replication cohort sizes, or 55% female figure. (LLM, conf=0.87)
- Supportedcites [10] Gill D, Monori G, Tzoulaki I, Dehghan A. Iron Status and Risk of Stroke. Stroke. 2018; 49(12): 2815– 21. 10.1161/STROKEAHA.118.022701 30571402 PMC6257507 source
The Methods section (page not provided) says the Genetics of Iron Status Consortium meta-analysis combined 48,972 European subjects. It names rs1800562, rs1799945, and rs855791 as the three loci associated with concordant changes in all four iron-status biomarkers. (LLM, conf=0.93)
plainn = 48,972- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“our study pooled MR estimates obtained using all available genetic instruments for iron status, rather than focusing on those related to hereditary hemochromatosis [42]”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Discussion
What the sources say
- Supportedcites [42] Pilling LC, Tamosauskaite J, Jones G, Wood AR, Jones L, Kuo CL, et al Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ. 2019; 364: k5222 10.1136/bmj.k5222 30651232 PMC6334179 source
The cited paper’s Methods > Mendelian randomisation section describes MR analyses using HFE genotype groups associated with hereditary haemochromatosis. That supports the contrast for which this paper is cited: its MR analysis focused on those genotypes. The statement about what the citing authors pooled describes their own study, not the cited paper. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
37 more claims · 5 with their cited sources checked
Create a free account to see all 70 claims and to verify the 6 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“however, it requires that the pleiotropic effects are independent of the variant–exposure associations (referred to as the Instrument Strength Independent of Direct Effect (InSIDE) assumption) 17 .”
From Guidelines for performing Mendelian randomization investigations (2020) · cites this paper as [17]
Experimental — accuracy not yet measured
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationMachiela, M. J., & Chanock, S. J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv402 · Cited by 2,069
Burgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
Calculating statistical power in Mendelian randomization studies.
Brion, M.-J. A., Shakhbazov, K., & Visscher, P. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt179 · Cited by 1,751
Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome
Greco M, F. D., Minelli, C., Sheehan, N. A., & Thompson, J. R. (2015) · Statistics in Medicine · doi:10.1002/sim.6522 · Cited by 1,700
Using multiple genetic variants as instrumental variables for modifiable risk factors
Palmer, T. M., Lawlor, D. A., Harbord, R. M., Sheehan, N. A., Tobias, J. H., Timpson, N. J., Smith, G. D., & Sterne, J. A. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280210394459 · Cited by 1,289
Denny, J. C., Bastarache, L., Ritchie, M. D., Carroll, R. J., Zink, R., Mosley, J. D., Field, J. R., Pulley, J. M., Ramirez, A. H., Bowton, E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2749 · Cited by 1,013
Daily oral iron supplementation during pregnancy
Peña-Rosas, J. P., De-Regil, L. M., Dowswell, T., & Viteri, F. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub4 · Cited by 615
Daily oral iron supplementation during pregnancy
Peña-Rosas, J. P., De-Regil, L. M., Garcia-Casal, M. N., & Dowswell, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub5 · Cited by 565
Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation
Wish, J. B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01490506 · Cited by 556
What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?
Smith, G. D., & Ebrahim, S. (2005) · BMJ · doi:10.1136/bmj.330.7499.1076 · Cited by 545
Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.
Swerdlow, D. I., Kuchenbaecker, K. B., Shah, S., Sofat, R., Holmes, M. V., White, J., Mindell, J. S., Kivimaki, M., Brunner, E. J., Whittaker, J. C., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw088 · Cited by 387
Puig, S., Askeland, E., & Thiele, D. J. (2005) · Cell · doi:10.1016/j.cell.2004.11.032 · Cited by 382
Wei, W.-Q., Bastarache, L. A., Carroll, R. J., Marlo, J. E., Osterman, T. J., Gamazon, E. R., Cox, N. J., Roden, D. M., & Denny, J. C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175508 · Cited by 379
Tolerability of different oral iron supplements: a systematic review
Cancelo-Hidalgo, M. J., Castelo-Branco, C., Palacios, S., Haya-Palazuelos, J., Ciria-Recasens, M., Manasanch, J., & Pérez-Edo, L. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761599 · Cited by 320
Sequestration and scavenging of iron in infection
Parrow, N. L., Fleming, R. E., & Minnick, M. F. (2013) · Infection and Immunity · doi:10.1128/iai.00602-13 · Cited by 261
Intermittent oral iron supplementation during pregnancy
Peña-Rosas, J. P., De-Regil, L. M., Gomez Malave, H., Flores-Urrutia, M. C., & Dowswell, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009997.pub2 · Cited by 258
Bowden, J., Hemani, G., & Davey Smith, G. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy185 · Cited by 251
An update on iron chelation therapy.
(2012) · Europe PMC (PubMed Central) · doi:10.2450/2012.0008-12 · Cited by 233
Dale, S. E., Doherty-Kirby, A., Lajoie, G., & Heinrichs, D. E. (2004) · Infection and Immunity · doi:10.1128/iai.72.1.29-37.2004 · Cited by 232
DeLoughery, T. G. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.09.004 · Cited by 231
Oral iron supplements for children in malaria-endemic areas
Neuberger, A., Okebe, J., Yahav, D., & Paul, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006589.pub4 · Cited by 220
Association of hemochromatosis with infectious diseases: expanding spectrum
Khan, F. A., Fisher, M. A., & Khakoo, R. A. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2007.04.007 · Cited by 216
Padmanabhan, S., Carty, L., Cameron, E., Ghosh, R. E., Williams, R., & Strongman, H. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-018-0442-4 · Cited by 208
Pilling, L. C., Tamosauskaite, J., Jones, G., Wood, A. R., Jones, L., Kuo, C.-L., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · BMJ · doi:10.1136/bmj.k5222 · Cited by 198
Daily iron supplementation for improving anaemia, iron status and health in menstruating women
Low, M. S. Y., Speedy, J., Styles, C. E., De-Regil, L. M., & Pasricha, S.-R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009747.pub2 · Cited by 178
Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
Pichler, I., Del Greco M., F., Gögele, M., Lill, C. M., Bertram, L., Do, C. B., Eriksson, N., Foroud, T., Myers, R. H., PD GWAS Consortium, et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001462 · Cited by 173
Self-citationTaylor, A. E., Davies, N. M., Ware, J. J., VanderWeele, T., Smith, G. D., & Munafò, M. R. (2014) · Economics & Human Biology · doi:10.1016/j.ehb.2013.12.002 · Cited by 166
Bates, C. S., Montañez, G. E., Woods, C. R., Vincent, R. M., & Eichenbaum, Z. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1042-1055.2003 · Cited by 154
Oral manifestations and blood profile in patients with iron deficiency anemia
Wu, Y., Wang, Y., Chang, J. Y., Cheng, S., Chen, H., & Sun, A. (2014) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2013.11.010 · Cited by 149
Management of Iron Deficiency Anemia.
(2015) · PubMed Central · Cited by 136
Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis
Ahmed, U. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i34.4651 · Cited by 121
Iron Status and Risk of Stroke: A Mendelian Randomization Study
Gill, D., Monori, G., Tzoulaki, I., & Dehghan, A. (2018) · Stroke · doi:10.1161/strokeaha.118.022701 · Cited by 110
Self-citationA simulation study investigating power estimates in phenome-wide association studies
Verma, A., Bradford, Y., Dudek, S., Lucas, A. M., Verma, S. S., Pendergrass, S. A., & Ritchie, M. D. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2135-0 · Cited by 109
Oral iron acutely elevates bacterial growth in human serum
Cross, J. H., Bradbury, R. S., Fulford, A. J., Jallow, A. T., Wegmüller, R., Prentice, A. M., & Cerami, C. (2015) · Scientific Reports · doi:10.1038/srep16670 · Cited by 108
Mendelian Randomization using Public Data from Genetic Consortia
Thompson, J. R., Minelli, C., & Del Greco M, F. (2016) · The International Journal of Biostatistics · doi:10.1515/ijb-2015-0074 · Cited by 98
Li, X., Meng, X., Spiliopoulou, A., Timofeeva, M. N., Wei, W., Gifford, A., Shen, X., He, Y., Varley, T., McKeigue, P., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212534 · Cited by 98
Self-citationMillard, L. A. C., Davies, N. M., Timpson, N. J., Tilling, K., Flach, P. A., & Smith, G. D. (2015) · Scientific Reports · doi:10.1038/srep16645 · Cited by 96
Gill, D., Del Greco M., F., Walker, A. P., Srai, S. K. S., Laffan, M. A., & Minelli, C. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309757 · Cited by 95
Self-citationDe-Regil, L. M., Jefferds, M. E. D., & Peña-Rosas, J. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009666.pub2 · Cited by 92
Different degrees of moderate iron deficiency modulate lipid metabolism of rats
Stangl, G. I., & Kirchgessner, M. (1998) · Lipids · doi:10.1007/s11745-998-0285-8 · Cited by 84
Mercado, C. I., DeSimone, A. K., Odom, E., Gillespie, C., Ayala, C., & Loustalot, F. V. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6447a1 · Cited by 84
Iron for restless legs syndrome
Trotti, L. M., Bhadriraju, S., & Becker, L. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007834.pub2 · Cited by 82
Current applications of therapeutic phlebotomy.
(2014) · Europe PMC (PubMed Central) · doi:10.2450/2013.0299-12 · Cited by 65
Management of anaemia in chronic kidney disease: summary of updated NICE guidance
Padhi, S., Glen, J., Pordes, B. A. J., et al. (2015) · BMJ · doi:10.1136/bmj.h2258 · Cited by 61
The management of iron deficiency anemia.
BROWN, E. B. (1958) · PubMed · Cited by 61
Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Sebastiani, G., & Pantopoulos, K. (2011) · Metallomics · doi:10.1039/c1mt00082a · Cited by 57
Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis
Benyamin, B., Esko, T., Ried, J. S., Radhakrishnan, A., Vermeulen, S. H., Traglia, M., Gögele, M., Anderson, D., Broer, L., Podmore, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms5926 · Cited by 30
Iron chelators for acute stroke
van der Loo, L. E., Aquarius, R., Teernstra, O., Klijn, C. J. M., Menovsky, T., van Dijk, J. M. C., Bartels, R., & Boogaarts, H. D. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009280.pub3 · Cited by 24
De‐Regil, L. M., Jefferds, M. E., & Peña‐Rosas, J. P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009666 · Cited by 14
Koga, A. (1985) · PubMed · Cited by 10
Iron chelators for acute stroke
Ma, J., You, C., & Li, H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009280.pub2 · Cited by 9
Micronutrient Fortification at Child-Care Centers Reduces Anemia in Young Children
Arcanjo, F. P. N., da Costa Rocha, T. C., Arcanjo, C. P. C., & Santos, P. R. (2019) · Journal of Dietary Supplements · doi:10.1080/19390211.2018.1474987 · Cited by 8
Iron chelators for acute stroke
Ma, J., You, C., & Hao, L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009280 · Cited by 5
(2014) · PubMed Central
Cited by
Guidelines for performing Mendelian randomization investigations
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.1 · Cited by 1,834
Self-citationGuidelines for performing Mendelian randomization investigations
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.2 · Cited by 1,273
Self-citationGuidelines for performing Mendelian randomization investigations: update for summer 2023
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Kutalik, Z., Holmes, M. V., Minelli, C., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.3 · Cited by 721
Self-citationWang, X., Fang, X., Zheng, W., Zhou, J., Song, Z., Xu, M., Min, J., & Wang, F. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab454 · Cited by 140
“No causal relationship has been identified previously between instrumented iron status and diabetes using the MR approach (22, 23).”
BackgroundMethodIron, glucose and fat metabolism and obesity: an intertwined relationship
Hilton, C., Sabaratnam, R., Drakesmith, H., & Karpe, F. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01299-0 · Cited by 141
“Although T2DM was not associated with any of the SNPs, hypercholesterolaemia was, suggesting a causal effect of iron status on lipid metabolism [96].”
Background
Metadata
- Authors
- Gill, D., Benyamin, B., Moore, L. S. P., Monori, G., Zhou, A., Koskeridis, F., Evangelou, E., Laffan, M., Walker, A. P., Tsilidis, K. K., Dehghan, A., Elliott, P., Hyppönen, E., & Tzoulaki, I.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Imperial College Healthcare NHS Trust (GB)
- University of South Australia (AU)
- University of Ioannina (GR)
- University College London (GB)
- Public Health England (GB)
- Corresponding author
- Gill, Dipender
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-06-20
- Volume
- 16
- Issue
- 6
- Pages
- e1002833
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6586257
- OpenAlex
- W2949626096
- Cited by
- 63
- References
- 67
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 18 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 2
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Alzheimer's Society
- National Institute for Health and Care Research
- Imperial College London
- Public Health England (MR/L01341X/1)
- UK Dementia Research Institute
- LEO Pharma
- Medical Research Council (MR/L01341X/1)
- National Health and Medical Research Council (1079583, 1084417)
- NIHR Imperial Biomedical Research Centre
- Health Data Research UK
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- iron status, serum iron, ferritin, transferrin saturation, transferrin, HFE gene, TMPRSS6, iron deficiency anemia, hypercholesterolemia, iron overload
- MeSH terms
- Adult, Aged, Female, Humans, Iron, Male, Middle Aged, Phenotype, Prospective Studies, Cohort Studies, Biomarkers, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.